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Introduction
The incidence and prevalence of end-stage renal dis-
ease (ESRD) continue to grow worldwide. According
to data collected from 120 countries with dialysis pro-
grams, about 1.9 million people were receiving renal
replacement therapy at the end of 2005. Among these
individuals, 445,000 (23%) underwent kidney transplan-
tation (KT) [1]. With improved surgical techniques and
immunosuppression, KT is becoming increasingly preva-
lent and is the most effective renal replacement therapy
for ESRD. In particular, the number of women undergo-
ing KT during the childbearing period is increasing [2,3].
These women had various menstrual problems after they
were diagnosed with ESRD and underwent KT [2,3].
Laparoscopically assisted vaginal hysterectomy (LAVH)
for the treatment of adenomyosis with menorrhagia 
or dysmenorrhea after KT has many advantages for
patients who are immunosuppressed, such as reduced
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SUMMARY
Objective: With improvements in immunosuppression and surgical techniques, more women are under-
going kidney transplantation (KT) for management of end-stage renal disease. Location of the trans-
planted pelvic kidney and transplanted ureter must be taken into consideration when performing pelvic
surgery. We demonstrate that laparoscopically assisted vaginal hysterectomy (LAVH) can be successfully
performed in patients who had previously undergone KT.
Materials and Methods: We prospectively enrolled four patients requiring operation for symptomatic
adenomyosis after KT. LAVH was performed in these cases after initial uterine artery ligation during
laparoscopy.
Results: The median age of the patients was 44 years (range, 40–46 years) and the extirpated uterine
weight was 195 g (range, 160–380 g). Intraoperatively, the median operation time was 147.5 minutes
(range, 105–175 minutes) and the blood loss was 50 mL (range, 50–100 mL). There was mild pelvic adhe-
sion in two cases. The postoperative recovery was good in all patients with oral intake, flatus passage, and
ambulation within 1 day after operation. The median intramuscular meperidine requirements were 25 mg
(range, 0–100 mg) and the hospital stay was 4 days (range, 3–8 days). There were no major complications
in these cases except one with mild postoperative fever.
Conclusion: LAVH may be a safe and effective treatment for treating patients with adenomyosis after KT.
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postoperative pain, less need for analgesia and shorter
hospitalization. It, therefore, decreases the risk of nosoco-
mial infections, and allows for a rapid return to oral intake
and, hence, continuation of immunosuppressive therapy
[4–8]. However, because of the altered location of the
transplanted kidney and ureter, LAVH is complicated
and risky in patients who have undergone KT.
The aims of this study were to evaluate the feasibil-
ity and clinical outcomes of LAVH in patients with prior
KT. For reducing the blood loss during operation, we
first ligated the bilateral uterine arteries during laparo-
scopy [9]. The possible impact of KT on laparoscopic
surgery was also illustrated.
Materials and Methods
We prospectively enrolled four patients requiring sur-
gery for symptomatic adenomyosis after KT. LAVH
was performed in these cases after initially ligating the
uterine arteries during laparoscopy [9]. The insufflation
technique of LAVH in these KT patients is crucial and
risky. Before operation, we screened these patients for
detection of possible visceroparietal adhesions and
selection of the site for trocar insertion in laparoscopic
surgery by real-time anterior abdominal ultrasound
imaging [10].
In brief, patients were positioned for laparoscopy
in the dorsal lithotomy position. A uterine manipulator
was placed with continuous drainage of the bladder.
One 10-mm trocar was inserted through the umbilicus
to hold the optic camera. One 5-mm trocar along with
another 10-mm trocar was inserted in the lower abdo-
men; their locations were adjusted according to uterine
size and the side of the transplanted kidney. Patients
with a large uterus required a more cephalad insertion
position [11]. A more central insertion position was
taken at the side of the transplanted kidney. LAVH
began with electrocoagulation and transection of the
bilateral round ligaments. In patients who desired to
preserve the adnexa, the fallopian tube and ovarian
ligament were transected; whereas in those who pre-
ferred salpingo-oophorectomy, the infundibulopelvic
ligaments were isolated, ligated, and transected. The
bilateral uterine arteries were identified and ligated by
extracorporeal ties through retrograde umbilical liga-
ment tracking [9], and the vesicouterine peritoneum was
opened with scissors. The vaginal procedures began with
anterior and posterior colpotomy. The vesicocervical,
cardinal and uterosacral ligaments were transected.
Because the uterine vessels had been secured laparo-
scopically, volume reduction techniques such as bisec-
tion, coring, myoma enucleation or morcellation could
be done discretionally without much bleeding of larger
uteri. The duration of LAVH was calculated from inser-
tion of the Veress needle to the last suture of skin closure.
Blood loss was estimated by calculating the difference
between the volume of fluid aspirated and the weight
difference of the gauzes used before and after surgery.
A minimum of 50 mL was recorded for cases with little
estimated blood loss. At the end of surgery, the removed
uteri were weighed before fixation in formalin for histo-
logic evaluation. Complications were defined as those
events requiring active treatment and a prolonged 
hospital stay.
Results
The baseline characteristics of the four patients are
listed in Table 1. All patients complained of hypermen-
orrhea or dysmenorrhea after KT. The median age of
patients was 44 years (range, 40–46 years). All were
diagnosed with adenomyosis, two combined with
leiomyoma. Their median parity was 2.5. Three patients
had previous vaginal delivery and two had previous
cesarean section. Case 3 had a larger body mass index
(BMI), 30.33 kg/m2, than the other three patients. All
patients had previous KT and Case 4 had simultane-
ous pancreas–kidney transplantation (SPK). She received
SPK in 1994, but a second pancreatic transplantation
in 1995 and a second KT in 1998 because of dysfunc-
tion of previous transplants. The Figure shows the
images of Case 4 under laparoscopy and the uterus extir-
pated by LAVH. Three patients had severe anemia and
received transfusion of packed red blood cells before
surgery. There was one right ovarian endometrioma in
Case 2, and LAVH plus cystectomy was performed.
Table 2 lists the clinical outcomes and complica-
tions. The median extirpated uterine weight was 195 g
(range, 160–380 g). Intraoperatively, the median oper-
ative time was 147.5 minutes (range, 105–175 min-
utes) and the average blood loss was 50 mL (range,
50–100 mL). The time to flatus passage, oral intake and
ambulation was all within 1 day after operation. Mild
pelvic adhesion was found in Cases 2 and 4. Little post-
operative analgesia was required in these four patients.
Although severe anemia before operation was noted in
three patients, there was no need for more blood trans-
fusion during or after operation, and the hemoglobin
level was still satisfactory 2 months after LAVH. The
median hospital stay was 4 days. There was no compli-
cation except one postoperative fever. In Case 3, fever
with body temperature up to 38°C and leukocytosis
with a white blood count up to 16,630/μL were noted
on postoperative day 1. The body temperature subsided
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Table 1. Baseline characteristics of four patients with adenomyosis after kidney transplantation (KT) receiving laparoscopi-
cally assisted vaginal hysterectomy with bilateral uterine artery ligation through retrograde umbilical ligament tracking
Case 1 Case 2 Case 3 Case 4
Age (yr) 44 40 44 46
Diagnosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis
Leiomyoma Right ovarian  Leiomyoma
endometrioma
Chief complaint Hypermenorrhea Hypermenorrhea Dysmenorrhea Hypermenorrhea
Dysmenorrhea
Anemia + + − +
Preoperative PRBC 2,500 500 Nil 1,500
transfusion (mL)
BMI (kg/m2) 19.68 19.37 30.33 21.82
Gravidity 3 3 3 3
Parity 3 1 3 2
Previous vaginal delivery, n 3 0 3 1
Previous cesarean section, n 0 1 0 1
Previous pelvic surgery KT KT KT SPK
PT
KT
Additional operation Nil Right ovarian Nil Nil
cystectomy
Adhesion – + − +
+ = present; – = absent; PRBC = packed red blood cells; BMI = body mass index; PT = pancreas transplantation; SPK = simultaneous pancreas–kidney 
transplantation.
to 37.8°C in the following 2 days and to normal on
postoperative day 4 after treatment with intravenous
cefazolin (1 g every 6 hours). These four patients were
followed up at 6 weeks and 12 weeks after operation
without morbidity.
Discussion
With improvements in immunosuppression and surgi-
cal techniques, more women are undergoing KT for
management of ESRD. The location of the transplanted
pelvic kidney and transplanted ureter must be taken
into consideration when performing pelvic surgery. In this
study, all patients had KT and one had SPK. Previous
abdominal surgery or peritonitis may result in adhe-
sions between the viscera and abdominal wall, and this
can lead to reduction or loss of visceral slide. A reduc-
tion in slide was considered a positive sign of underly-
ing adhesions [12]. Before operation, we screened these
patients for detection of possible visceroparietal adhe-
sions and selection of the site for trocar insertion in
laparoscopic surgery by real-time anterior abdominal
ultrasound imaging [10]. The site of choice for the
Veress needle was the umbilical skin fold, because vis-
ceral slide was not reduced in the periumbilical area.
Laparoscopy confirmed no adhesion of viscera to the
undersurface of the umbilicus. An adhesion was found
in the pelvis as a result of endometriosis in Case 2 and
a mild bowel adhesion to the uterus in Case 4 (Figure),
which was not related to trocar insertion at the abdom-
inal wall. Previous studies [13] reported a complication
rate of 5–7% with urinary tract injury (renal pelvis, ureter,
and bladder) by laparoscopic fenestration for the sur-
gical treatment of posttransplantation lymphocele.
Bailey et al [14] reported that laparoscopy should 
be considered the first-line therapy. We inserted a
ureteral stent into the transplanted ureter to prevent
ureteral injury in the first case (Case 1), but it was not
necessary as there was no obvious adhesion after KT in
these cases.
Intraoperatively, Cases 2 and 3 needed more oper-
ative time than the other two cases, possibly as a result
of a high uterine weight in Case 2 [15] and a high BMI
in Case 3 [16]. Although O’Hanlan et al [17] reported
similar mean operative times and blood loss among
groups stratified according to BMI in total laparoscopic
hysterectomy, Heinberg et al [16] reported that proce-
dure completion for obese patients was more likely to
require at least 2 hours (61%) compared with non-obese
patients (38%). Obesity conveyed a threefold increased
‘risk of operative blood loss exceeding 500 mL when
compared with non-obese patients [16]. Blood sparing
has an important place in hysterectomy in patients with
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Table 2. Clinical outcomes and complications in patients with adenomyosis after kidney transplantation receiving laparo-
scopically assisted vaginal hysterectomy with bilateral uterine artery ligation through retrograde umbilical ligament tracking
Case 1 Case 2 Case 3 Case 4 Mean ± SD
Uterine weight (g) 160 380 180 210 233 ± 100
Operative time (min) 130 175 165 105 144 ± 32
Blood loss (mL) 50 100 50 50 63 ± 25
Flatus passage (hr) 18 24 24 24 23 ± 3
Oral intake (hr) 18 24 18 24 21 ± 4
Ambulation (hr) 18 24 16 14 18 ± 4
Dose of meperidine 0 1 2 0 0.3 ± 0.6
(50 mg/ampule)
Hospital stay (d) 3 3 8 5 4.8 ± 2.4
Hemoglobin (g/dL)
Before hypermenorrhea 10.0 NA 11.7
Before blood transfusion 4.4 8.7 NA 5.9
Pre-operation 12.9 10.9 12.7 10.5
2 months post-operation 10.6 11.8 11.3 10.3
Postoperative fever − − + − −
SD = standard deviation; NA = not available; − = absent; + = present.
A B
C D
Figure. Case 4 under laparoscopically assisted vaginal hysterectomy (LAVH). (A) Enlarged uterus (asterisk) and the first dis-
located transplanted kidney (arrowhead) were seen after pneumoperitoneum. Notice the bowel adhesion to the posterior
uterine surface (arrow). (B) The second transplanted pancreas was covered by fat. (C) Notice the location of the first dislo-
cated (arrowhead) and the second transplanted kidney (asterisk) after LAVH. (D) Extirpated uterus, weight 210 g, by LAVH
with morcellation via the vaginal approach.
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a large fibroid uterus or preoperative anemia. In our
cases, the blood loss was minimal (range, 50–100 mL) in
all of the four patients, including Case 3 with a larger
BMI (30.33 kg/m2) and Case 2 with a heavier uterus
(380 g). The decreased blood loss might result from
uterine artery ligation in our operation procedure [18].
LAVH resulted in rapid recovery with oral intake, flatus
passage and ambulation within 1 day after operation
(Table 2). In addition, it benefited from a small wound
and little analgesic requirement (Table 2). These are
important, because patients after KT may take oral
immunosuppressant drugs which increase wound
complications [19].
In conclusion, LAVH may be a safe and effective
treatment for adenomyosis after KT. However, the
findings in this study should be considered preliminary
because of the small number of patients; further large-
sized studies are necessary.
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